Role de la scintigraphie au DMSA dans la prise en charge des pyelonephrites de l'enfant. [Role of DMSA scintigraphy in managing pediatric pyelonephritis]
Détails
ID Serval
serval:BIB_574AD23C94BA
Type
Article: article d'un périodique ou d'un magazine.
Sous-type
Synthèse (review): revue aussi complète que possible des connaissances sur un sujet, rédigée à partir de l'analyse exhaustive des travaux publiés.
Collection
Publications
Institution
Titre
Role de la scintigraphie au DMSA dans la prise en charge des pyelonephrites de l'enfant. [Role of DMSA scintigraphy in managing pediatric pyelonephritis]
Périodique
Archives de Pediatrie
ISSN
0929-693X
Statut éditorial
Publié
Date de publication
1998
Peer-reviewed
Oui
Volume
5 Suppl 3
Pages
285S-289S
Notes
English Abstract
Journal Article
Review
Journal Article
Review
Résumé
Pyelonephritis in children may lead to irreversible renal damage and eventually to arterial hypertension and renal insufficiency. Inflammation plays a central role in the pathogenesis of pyelonephritis. Dimercaptosuccinic acid (DMSA) scintigraphy permits detection of acute renal lesions and renal scars with high sensitivity and specificity. In our experience 60% of patients who had acute renal lesions on DMSA scintigraphy during pyelonephritis develop scars. Young age appears to be not a risk factor, as in our experience 70% of children older than 5 years develop scars compared to 40% for children younger than 1 year. In addition, only 40% of patients who develop scars have vesicoureteral reflux. DMSA scintigraphy may provide answers to important clinical questions: what is the optimal length of treatment of pyelonephritis? Is parenteral treatment necessary? What is the best treatment of vesicoureteral reflux? DMSA scintigraphy permits therapeutical decision-making according to the renal involvement in each of our patients.
Mots-clé
Acute Disease
Adolescent
Child
Child, Preschool
Female
Humans
Infant
Male
Patient Care Planning
Pyelonephritis/etiology/*radionuclide imaging
Risk Factors
Technetium Tc 99m Dimercaptosuccinic Acid/*diagnostic use
Pubmed
Création de la notice
15/01/2008 15:28
Dernière modification de la notice
20/08/2019 15:11